 | • レポートコード：B-GIR09F3281 • 出版社/出版日：GlobalInfoResearch / 2019年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、神経芽腫薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法、免疫療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。神経芽腫薬の世界市場概観、企業動向、企業別神経芽腫薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・神経芽腫薬の市場概観 ・神経芽腫薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・神経芽腫薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・神経芽腫薬の世界市場規模 ・神経芽腫薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・神経芽腫薬のアメリカ市場規模推移 ・神経芽腫薬のカナダ市場規模推移 ・神経芽腫薬のメキシコ市場規模推移 ・神経芽腫薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・神経芽腫薬のドイツ市場規模推移 ・神経芽腫薬のイギリス市場規模推移 ・神経芽腫薬のロシア市場規模推移 ・神経芽腫薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・神経芽腫薬の日本市場規模推移 ・神経芽腫薬の中国市場規模推移 ・神経芽腫薬の韓国市場規模推移 ・神経芽腫薬のインド市場規模推移 ・神経芽腫薬の東南アジア市場規模推移 ・神経芽腫薬の南米市場分析（ブラジル、アルゼンチン等） ・神経芽腫薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・神経芽腫薬の種類別分析/販売量、売上、市場シェア（化学療法、免疫療法、その他） ・神経芽腫薬の用途別分析/市場規模（病院、診療所、その他） ・神経芽腫薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・神経芽腫薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.
Scope of the Report:
The global Neuroblastoma Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuroblastoma Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Neuroblastoma Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuroblastoma Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Teva Pharmaceutical
Johnson & Johnson
Bristol-Myers Squibb
United Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemotherapy
Immunotherapy
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
Table of Contents
1 Neuroblastoma Drugs Market Overview
1.1 Product Overview and Scope of Neuroblastoma Drugs
1.2 Classification of Neuroblastoma Drugs by Types
1.2.1 Global Neuroblastoma Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Neuroblastoma Drugs Revenue Market Share by Types in 2018
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Global Neuroblastoma Drugs Market by Application
1.3.1 Global Neuroblastoma Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Neuroblastoma Drugs Market by Regions
1.4.1 Global Neuroblastoma Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Neuroblastoma Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuroblastoma Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroblastoma Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Neuroblastoma Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroblastoma Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Neuroblastoma Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Neuroblastoma Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Teva Pharmaceutical
2.2.1 Business Overview
2.2.2 Neuroblastoma Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Pharmaceutical Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Neuroblastoma Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Neuroblastoma Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 United Therapeutics
2.5.1 Business Overview
2.5.2 Neuroblastoma Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 United Therapeutics Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Neuroblastoma Drugs Market Competition, by Players
3.1 Global Neuroblastoma Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroblastoma Drugs Players Market Share
3.2.2 Top 10 Neuroblastoma Drugs Players Market Share
3.3 Market Competition Trend
4 Global Neuroblastoma Drugs Market Size by Regions
4.1 Global Neuroblastoma Drugs Revenue and Market Share by Regions
4.2 North America Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
5 North America Neuroblastoma Drugs Revenue by Countries
5.1 North America Neuroblastoma Drugs Revenue by Countries (2014-2019)
5.2 USA Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
6 Europe Neuroblastoma Drugs Revenue by Countries
6.1 Europe Neuroblastoma Drugs Revenue by Countries (2014-2019)
6.2 Germany Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
6.4 France Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Neuroblastoma Drugs Revenue by Countries
7.1 Asia-Pacific Neuroblastoma Drugs Revenue by Countries (2014-2019)
7.2 China Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
7.5 India Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
8 South America Neuroblastoma Drugs Revenue by Countries
8.1 South America Neuroblastoma Drugs Revenue by Countries (2014-2019)
8.2 Brazil Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Neuroblastoma Drugs by Countries
9.1 Middle East and Africa Neuroblastoma Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
10 Global Neuroblastoma Drugs Market Segment by Type
10.1 Global Neuroblastoma Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Neuroblastoma Drugs Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2014-2024)
10.4 Immunotherapy Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Neuroblastoma Drugs Market Segment by Application
11.1 Global Neuroblastoma Drugs Revenue Market Share by Application (2014-2019)
11.2 Neuroblastoma Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Neuroblastoma Drugs Market Size Forecast (2019-2024)
12.1 Global Neuroblastoma Drugs Market Size Forecast (2019-2024)
12.2 Global Neuroblastoma Drugs Market Forecast by Regions (2019-2024)
12.3 North America Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
12.6 South America Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Neuroblastoma Drugs Picture
Table Product Specifications of Neuroblastoma Drugs
Table Global Neuroblastoma Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Neuroblastoma Drugs Revenue Market Share by Types in 2018
Figure Chemotherapy Picture
Figure Immunotherapy Picture
Figure Others Picture
Table Global Neuroblastoma Drugs Revenue (Million USD) by Application (2014-2024)
Figure Neuroblastoma Drugs Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Neuroblastoma Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Neuroblastoma Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Neuroblastoma Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Neuroblastoma Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Neuroblastoma Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Neuroblastoma Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Neuroblastoma Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Neuroblastoma Drugs Type and Applications
Table Pfizer Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Neuroblastoma Drugs Type and Applications
Table Teva Pharmaceutical Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Neuroblastoma Drugs Type and Applications
Table Johnson & Johnson Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Neuroblastoma Drugs Type and Applications
Table Bristol-Myers Squibb Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table United Therapeutics Basic Information, Manufacturing Base and Competitors
Table United Therapeutics Neuroblastoma Drugs Type and Applications
Table United Therapeutics Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Neuroblastoma Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Neuroblastoma Drugs Revenue Share by Players (2014-2019)
Figure Global Neuroblastoma Drugs Revenue Share by Players in 2017
Figure Global Neuroblastoma Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Neuroblastoma Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Neuroblastoma Drugs Revenue Market Share in 2018
Figure Global Neuroblastoma Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Neuroblastoma Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Neuroblastoma Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Neuroblastoma Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Neuroblastoma Drugs Revenue Market Share by Regions in 2018
Figure North America Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure South America Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Table North America Neuroblastoma Drugs Revenue by Countries (2014-2019)
Table North America Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Neuroblastoma Drugs Revenue Market Share by Countries in 2018
Figure USA Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Table Europe Neuroblastoma Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Neuroblastoma Drugs Revenue Market Share by Countries in 2018
Figure Germany Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure UK Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure France Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Neuroblastoma Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Neuroblastoma Drugs Revenue Market Share by Countries in 2018
Figure China Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure India Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Table South America Neuroblastoma Drugs Revenue by Countries (2014-2019)
Table South America Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Neuroblastoma Drugs Revenue Market Share by Countries in 2018
Figure Brazil Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Neuroblastoma Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroblastoma Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroblastoma Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Neuroblastoma Drugs Revenue and Growth Rate (2014-2019)
Table Global Neuroblastoma Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Neuroblastoma Drugs Revenue Share by Type (2014-2019)
Figure Global Neuroblastoma Drugs Revenue Share by Type (2014-2019)
Figure Global Neuroblastoma Drugs Revenue Share by Type in 2019
Table Global Neuroblastoma Drugs Revenue Forecast by Type (2019-2024)
Figure Global Neuroblastoma Drugs Market Share Forecast by Type (2019-2024)
Figure Global Chemotherapy Revenue Growth Rate (2014-2019)
Figure Global Immunotherapy Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Neuroblastoma Drugs Revenue by Application (2014-2019)
Table Global Neuroblastoma Drugs Revenue Share by Application (2014-2019)
Figure Global Neuroblastoma Drugs Revenue Share by Application (2014-2019)
Figure Global Neuroblastoma Drugs Revenue Share by Application in 2019
Table Global Neuroblastoma Drugs Revenue Forecast by Application (2019-2024)
Figure Global Neuroblastoma Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Neuroblastoma Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Neuroblastoma Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Neuroblastoma Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
Figure Europe Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
Figure South America Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Neuroblastoma Drugs Revenue Market Forecast (2019-2024)
世界のホジキンリンパ腫薬市場予測（～2024年） Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. Those affecte…- 世界のボツリヌス中毒症薬市場予測（～2024年） Botulism is a rare and potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. The disease begins with weakness, blurred vision, feeling tired, and trouble speaking. This may then be followed by weakness of the arms, chest muscles, and legs. Vomiting, swelling of…
- 特定がん免疫療法薬市場：世界及び中国市場分析・予測（～2024年） Specific Cancer Immunotherapy Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Specific Cancer Immunotherapy Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of th…
- 世界の咳止め薬市場予測（～2024年）：企業別、地域別、種類・用途別 Cough Suppressant, also known as cAntitussives, are widely used to relieve the symptoms of cough. They are substances which suppress the coughing itself. Examples are codeine, pholcodine, dextromethorphan, noscapine, and butamirate. Scope of the Report: The global Cough Suppressant Drugs market is v…
- 世界の間質性膀胱炎薬市場予測（～2024年）：企業別、地域別、種類・用途別 Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic bladder issue often associated with bladder pressure and pain, with occasional pain in either the lower abdomen, pelvic, or lower back. Scope of the Report: The global Interstitial Cystitis Drugs market is valued at xx …